International Scholarly Research Notices

Review Article

Prognostic Significance of Vascular Endothelial Growth Factor Serum Determination in Women with Ovarian Cancer

Univariate and multivariate analyses for disease free survival.


Variable	Author, year	No. cases	Cut-off	Univariate analisys RR,	Multivariate analisys RR,

	Tempfer et al., 1998 [21]	60	≥826 versus <826
VEGF (pg/mL)	Chen et al., 1999 [23]	56	NA
VEGF (pg/mL)	Harloziňska et al., 2004 [27]	314	≥750 versus <750

Stage	Tempfer et al., 1998 [21]	60	I/II versus III/IV
	Chen et al., 1999 [23]	56	I/II versus III/IV	NA
	Harloziňska et al., 2004 [27]	314	I/II versus III/IV

Grade	Tempfer et al., 1998 [21]	60	G1 versus G2/G3
	Chen et al., 1999 [23]	56	G1 versus G2/G3	NA
	Harloziňska et al., 2004 [27]	314	G1 versus G2/G3

Residual tumour size	Chen et al., 1999 [23]	56	≥2 versus <2	NA
Residual tumour size	Harloziňska et al., 2004 [27]	314	≥2 versus <2

Lymph node involvement	Tempfer et al., 1998 [21]	60	Yes versus No

Histological type	Chen et al., 1999 [23]	56	serous/mucinous versus others	NA
Histological type	Harloziňska et al., 2004 [27]	314	serous versus others

Age (years)	Harloziňska et al., 2004 [27]	314	≥62 versus <62

*:Subset of 40 patients with residual tumour size ≤2 cm; NA: not available data; NS: non-significant statistical analysis.